Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Jayasree K. Iyer to speak at summit on clinical AI for global health

Jayasree K. Iyer, CEO of the Access to Medicine Foundation, will speak at a summit on clinical AI for global health held by Harvard Medical School, where she will relay how the Access to Medicine Index can be used as an example for how to accelerate the uptake of AI health tools to improve healthcare in low- and middle-income countries.

Date

19 November 2025

Location

Boston

A summit on clinical AI for global health, “Creating Collaborative Action Plans to Improve Global Health Equity through Clinical AI Development,” will take place at Harvard Medical School’s Center for Bioethics in November.

Held under the Chatham House Rule, the two-day Summit will bring together global health stakeholders and experts in AI to identify actionable strategies to incentivise the development and uptake of AI health tools that have the potential to improve diagnosis, clinical decision making and treatment planning in low- and middle-income countries (LMICs).

Participants will collaborate to identify the next steps toward bringing these tools into use, forming coalitions to ensure progress continues following the event.

Jayasree K. Iyer, CEO of the Access to Medicine Foundation, will share how the Access to Medicine Index – published every two years since 2008 – can be seen as a model for coalition building through holding industry players accountable and incentivising them to prioritise creating equitable access to medicines in LMICs. Specifically, she will relay how this approach can be emulated to advance the uptake of AI for improving healthcare systems in LMICs.

Research hub

Explore our research reports and publications
Research

2024 Access to Medicine Index

19 November 2024
Research

Tracking progress of access strategies against patient reach goals

19 November 2024

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved